AU6912594A - Neurotransmitter transporter - Google Patents
Neurotransmitter transporterInfo
- Publication number
- AU6912594A AU6912594A AU69125/94A AU6912594A AU6912594A AU 6912594 A AU6912594 A AU 6912594A AU 69125/94 A AU69125/94 A AU 69125/94A AU 6912594 A AU6912594 A AU 6912594A AU 6912594 A AU6912594 A AU 6912594A
- Authority
- AU
- Australia
- Prior art keywords
- neurotransmitter transporter
- neurotransmitter
- transporter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Anesthesiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1994/005363 WO1995031539A1 (fr) | 1994-05-16 | 1994-05-16 | Vehicule de neurotransmetteur |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6912594A true AU6912594A (en) | 1995-12-05 |
Family
ID=22242563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU69125/94A Abandoned AU6912594A (en) | 1994-05-16 | 1994-05-16 | Neurotransmitter transporter |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0759978A4 (fr) |
JP (1) | JPH10500299A (fr) |
AU (1) | AU6912594A (fr) |
WO (1) | WO1995031539A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6084084A (en) * | 1996-02-21 | 2000-07-04 | Nps Pharmaceuticals, Inc. | Human metabotropic glutamate receptor |
EP0881290A3 (fr) * | 1997-05-27 | 1999-12-22 | Smithkline Beecham Plc | Véhicule de neurotransmetteur |
WO2001019854A2 (fr) * | 1999-09-15 | 2001-03-22 | Smithkline Beecham P.L.C. | Nouveaux composes |
CN1307007A (zh) * | 2000-01-21 | 2001-08-08 | 上海博道基因技术有限公司 | 一种新的多肽——人钠-神经传递素协同转运蛋白8,43和编码这种多肽的多核苷酸 |
GB2365432A (en) * | 2000-05-19 | 2002-02-20 | Glaxo Group Ltd | Neurotransmitter transporter polypeptide |
US20020031800A1 (en) * | 2000-09-05 | 2002-03-14 | Zhenya Li | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
AU2001295590A1 (en) * | 2000-10-05 | 2002-04-15 | Bayer Aktiengesellschaft | Regulation of human sodium-dependent neurotransmitter transporter |
AU2001293863A1 (en) * | 2000-10-05 | 2002-04-15 | Bayer Aktiengesellschaft | Regulation of human sodium-dependent monoamine transporter |
US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
-
1994
- 1994-05-16 AU AU69125/94A patent/AU6912594A/en not_active Abandoned
- 1994-05-16 WO PCT/US1994/005363 patent/WO1995031539A1/fr not_active Application Discontinuation
- 1994-05-16 EP EP94917383A patent/EP0759978A4/fr not_active Withdrawn
- 1994-05-16 JP JP7529590A patent/JPH10500299A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0759978A1 (fr) | 1997-03-05 |
JPH10500299A (ja) | 1998-01-13 |
WO1995031539A1 (fr) | 1995-11-23 |
EP0759978A4 (fr) | 1997-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU676586B2 (en) | Bone transporter | |
AU4040197A (en) | Microturbomachinery | |
AU3387997A (en) | Autonotification | |
AU4945197A (en) | Aminothiophenecarboxamides | |
AU4013397A (en) | Arylalkanoylpyridazines | |
AU6289594A (en) | Line transport system | |
AU4176997A (en) | 3-alkyl-3-phenyl-piperidines | |
AU2684197A (en) | Handleset | |
AU4218597A (en) | Superseat | |
AU5556998A (en) | 3-amino-1-cyanophenyl-uracils | |
AU2090897A (en) | Hydroxyhexahydropyridazines | |
AU3000197A (en) | Module transporter | |
AU6912594A (en) | Neurotransmitter transporter | |
AU5221598A (en) | Sweet-toy | |
AU3130597A (en) | Tristetraprolin | |
AU4604397A (en) | (o-acyl-p-n-acylamino-phenyl)-o-phosphoethanolamines | |
AU5002897A (en) | Gripper-accumulator | |
AU1597197A (en) | Thienoquinolines | |
AU3557397A (en) | Double-tau-profile | |
GB9623431D0 (en) | Transporter | |
AU1643797A (en) | Repeater-system | |
AUPM772594A0 (en) | Split-lock bar | |
AU4110897A (en) | Horse-nail | |
ZA943696B (en) | Neurotransmitter transporter | |
AU4716197A (en) | Transinduction |